While early results from the study raised concerns that long-term use of Prilosec or Nexium may have increased the risk of heart attacks, heart failure, and heart-related sudden death in those patients taking either one of the drugs compared to patients who received surgery, FDA's preliminary conclusion at this time is that this data does not suggest an increased risk of heart problems for the following reasons:
- While the initial data from this study suggested a difference between treatments in the rate of cardiovascular events, an updated report found that the number of patients who experienced heart problems was similar in both treatment groups.
- While both of these studies collected safety data, the study protocols did not specify how heart problems, such as heart attacks, were to be defined or documented. As a result, evaluating the information that has been gathered about the safety of either drug in these studies is difficult.
- Many of the patients who were chosen to have surgery withdrew from the study without ever undergoing the surgical procedure. The patients who did undergo surgery tended to be younger, and less likely to have a past history of heart problems or risk factors for heart problems, than those who were treated with one of the drugs. These differences between these two groups of patients could have biased the safety data from these studies.
- FDA’s conclusions are further supported by an additional analysis of 14 comparative studies of omeprazole, of which four were placebo-controlled. In these studies, there were fewer heart attacks or other heart problems reported in the patients treated with omeprazole compared to patients that were given a placebo.
Are you taking Prilosec or Nexium? What are your thoughts concerning this new information? Will you continue taking these medications, or will you ask your doctor for an alternative? Share your thoughts by clicking on the "comments" link below this post.